Intrinsic Value of S&P & Nasdaq Contact Us

Paratek Pharmaceuticals, Inc. PRTK NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — PRTK

Paratek Pharmaceuticals, Inc. (PRTK) has a market capitalization of $127.83M and trades at $2.23. The 52-week range is 1.29-3.65.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.9, Earnings Per Share (EPS) of $-1.17, annual revenue of $150.79M.

The stock has a beta of 1.70, a last dividend of $31.9730, operates in the Healthcare sector.

Trading Data
Current Price$2.23
52-Week Range1.29-3.65
Volume4.48M
Avg Volume (30D)599.68K
Market Cap$127.83M
Beta (1Y)1.70
Last Dividend$31.9730
Company
IPO Date2009-02-03
Employees268
CEOEvan Loh FACC, FAHA,
CountryUS
ExchangeNASDAQ Global Market
CurrencyUSD
ISINUS6993743029
CUSIP699374302
Income (Latest Year)
Revenue$150.79M
Gross Profit$127.73M
EBITDA$-44.9M
Operating Income$-46.21M
Net Income$-63.57M
EPS$-1.17
EPS Diluted$-1.17
Shares Outstanding$54.39M
Balance Sheet (Latest Year)
Total Assets$172.54M
Current Assets$136.84M
Cash & ST Investments$34.25M
Total Liabilities$343.58M
Total Debt$258.41M
Net Debt$224.17M
Total Equity$-171.04M
Debt / Equity-1.51
Valuation Ratios
P/E Ratio-1.9
P/S Ratio0.85
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message